Alzheimer’s Disease Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Alpha Cognition, Biogen, Eisai, Eli Lilly, Otsuka Pharma, Lundbeck, Suven Life Sciences, Roche

Alzheimer’s Disease Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Alpha Cognition, Biogen, Eisai, Eli Lilly, Otsuka Pharma, Lundbeck, Suven Life Sciences, Roche

The Key Alzheimer’s Disease Companies in the market include – Alpha Cognition, Biogen/Eisai, Eli Lilly, Otsuka Pharma/ Lundbeck, Suven Life Sciences, Roche, Annovis Bio, and others . The Alzheimer’s Disease

Read More

Multiple Sclerosis Market Outlook 2036: Growth Trends, Competitive Landscape, and Future Opportunities by 2034 – DelveInsight | Biogen, Immune Response BioPharma, ImCyse, Atara Bio, Emerald Health

The Key Multiple Sclerosis Companies in the market include – Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharmaceuticals, Sanofi, RemeGen, Gossamer Bio, 4D Pharma, HuniLife Biotechnology, Anokion, GSK

Read More

Non-Hodgkin Lymphoma Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma, Eli Lilly

(Las Vegas, Nevada, United States) – September 10, 2026: As per DelveInsight’s assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 180+ key companies continuously working towards developing 200 + Non-Hodgkin Lymphoma treatment

Read More

Prostate Cancer Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Bayer, J&J, Astellas Pharma, Pfizer, Janssen R&D, Tesaro, Sanofi, MacroGenics

The Key Prostate Cancer Companies in the market include – Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen Research & Development/Tesaro, Sanofi, MacroGenics, Candel Therapeutics, Kangpu Biopharmaceuticals,

Read More

Multiple Myeloma Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | Regeneron, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb

The Key Multiple Myeloma Companies in the market include – Regeneron Pharmaceuticals, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb, Carsgen Therapeutics, Cartesian Therapeutics, Gracell Biotechnology Shanghai Co., Ltd., CASI Pharmaceuticals, Sorrento

Read More

Type 2 Diabetes Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast – DelveInsight | Eli Lilly, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences

The Key Type 2 Diabetes Companies in the market include – Eli Lilly and Company, Regor Pharmaceuticals Inc., AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova, Sparrow Pharmaceuticals, HighTide

Read More

EGFR-NSCLC Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | Dizal Pharma, Eli Lilly, Cullinan Oncology, Taiho Pharma, AstraZeneca, J&J Innova

The Key Epidermal growth factor receptor-Non Small Cell Lung Cancer Companies in the market include – AstraZeneca, J&J Innovative Medicine, Hansoh Pharmaceutical, Cullinan Oncology/Taiho Pharmaceutical, Abbvie, Yuhan Corporation, Janssen Research

Read More

Obesity Market to Witness Strong Growth and Significant Market Expansion by 2036 – DelveInsight | Rhythm Pharma, Boehringer Ingelheim, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical

The Key Obesity Companies in the market include – Rhythm Pharma, Boehringer Ingelhium, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharmaceutical, Caliway Biopharmaceutics, Yuhan, Terns Pharmaceuticals, BioRestorative Therapies, SCOHIA

Read More

Pertussis Market Size, Share, Growth, Epidemiology and Forecast to 2036

DelveInsight’s latest report, “Pertussis – Market Insight, Epidemiology and Market Forecast – 2036,” provides a comprehensive assessment of the global Pertussis market, covering the United States, EU4 (Germany, France, Italy,

Read More

Triple Negative Breast Cancer Market to Reach Significant Growth by 2036, Driven by Advancements in Immunotherapy, Targeted Therapies, and Next-generation Treatment Approaches | DelveInsight

DelveInsight’s latest report, “Triple Negative Breast Cancer Market Insights, Epidemiology and Market Forecast – 2036,” provides a comprehensive analysis of the Triple Negative Breast Cancer (TNBC) market across the United

Read More

Malignant Pleural Effusion Market to Grow at 4.9% CAGR Through 2036, Driven by Rising Cancer Burden, Increasing Demand for Minimally Invasive Treatments, and Emerging Therapeutic Approaches | DelveIns

DelveInsight’s latest report, “Malignant Pleural Effusion Market Insights, Epidemiology and Market Forecast – 2036,” provides a comprehensive analysis of the Malignant Pleural Effusion (MPE) market across the United States, EU4

Read More

Shingles Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Shingles clinical trial analysis report delivers important insights into ongoing research of 20+ pipeline Shingles drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10, 2026- DelveInsight’s

Read More

Graft Versus Host Disease Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Graft versus host disease (GVHD) clinical trial analysis report delivers important insights into ongoing research of 50+ pipeline GVHD drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US)

Read More

Interstitial Lung Disease Market Size is Projected to Grow from USD 6 Billion at a CAGR of 8.7% By 2036| DelveInsight

Interstitial Lung Disease, also known as diffuse parenchymal lung disease, represents a heterogeneous group of lung disorders characterized by shared clinical, radiographic, physiologic, or pathologic features, with inflammatory and fibrotic

Read More

Sciatica Market Outlook 2032: Growth Trends, Competitive Landscape, and Future Opportunities – DelveInsight

The Sciatica Treatment Market is expected to grow at a significant CAGR during the study period (2019–2032), driven by rising disease incidence, greater diagnostic awareness, and an active late-stage pipeline.

Read More

The Global Vascular Grafts Market Size is projected to grow at a CAGR of 6.86% during the forecast period from 2025 to 2032 | DelveInsight

The Vascular Grafts market was valued at USD 1,863.09 million in 2024 and is projected to reach USD 3,153.39 million by 2032, growing at a CAGR of 6.86% during the

Read More

Graft Versus Host Disease Market to Reach Significant Growth by 2036, Driven by Rising Transplant Procedures, Targeted Therapies, and Emerging Cell-based Treatment Approaches | DelveInsight

DelveInsight’s latest report, “Graft Versus Host Disease Market Insights, Epidemiology and Market Forecast – 2036,” provides a comprehensive analysis of the Graft Versus Host Disease (GvHD) market across the United

Read More

Antibody Drug Conjugates Market Poised for Significant Growth Through 2034, Driven by Expanding Oncology Applications, Next-generation ADCs, and Advances in Targeted Cancer Therapy | DelveInsight

DelveInsight’s latest report, “Antibody Drug Conjugates Market Size, Target Population, Competitive Landscape & Market Forecast” provides a comprehensive analysis of the Antibody Drug Conjugates (ADC) market across the United States,

Read More

Radioligand Therapies Market Expected to Witness Significant Growth by 2036, Driven by Rising Cancer Burden, Precision Oncology, and Expansion of Next-generation Radioligand Therapies | DelveInsight

DelveInsight’s latest report, “Radioligand Therapies Market Size, Target Population, Competitive Landscape & Market Forecast,” provides a comprehensive analysis of the radioligand therapies market across the United States, EU4, the United

Read More

Sheikh Nawaf Bin Jassim Bin Jabr Al-Thani: Strategic Leadership in Sustainable Development and Investment

Sheikh Nawaf Bin Jassim Bin Jabr Al-Thani: Long-Term Vision, Sustainable Development and Community Value Across Markets Doha, Qatar, September 10, 2026 – Across different stages of Sheikh Nawaf Bin Jassim Bin Jabr

Read More